The Scotts Miracle-Gro Company (SMG) Earnings Call Transcript & Summary

November 3, 2021

New York Stock Exchange US Materials Chemicals earnings 99 min

Earnings Call Speaker Segments

Jim King

executive
#1

Hello, everyone, and thanks for joining us on The Scotts Miracle-Gro Fourth Quarter Conference Call. You've probably had a chance by now to look at the press release covering our fourth quarter and year-end, where we shared record results for the full year along with our initial guidance for fiscal 2022; there's plenty for us to get through this morning, with prepared remarks from our Chairman and CEO, Jim Hagedorn; our CFO, Cory Miller; and Hawthorne Division President, Chris Hagedorn. Once they've finished, we'll open things up for your questions. President and COO, Mike Lukemire, will be with us for that Q&A portion; because time is limited, we ask that each of you limit yourselves to 1 question and 1 follow-up. I'll be around after the call and in the days that follow to handle anything we can't get to or that requires more discussion. A reminder that forward-looking statements will be part of what we say today, so our actual results could differ materially from what we discuss. Please take a look at our Form 10-K, filed with the Securities and Exchange Commission, to familiarize yourself with the complete range of risk factors that could impact our results. This call is being recorded; an archived version will be available on the Investor Relations portion of our corporate website, scottsmiraclegro.com. Let's get going without further delay, and I'll hand things over to Jim Hagedorn to begin. Jim?

Jim Hagedorn

executive
#2

Thank you, Jim, and good morning. Over the past month, I've been mulling over the main themes I hoped to address today, and I've also devoted considerable time to considering precisely whom I wanted these remarks to reach. I won't devote much of my time to the quarter or to the year that's just ended, though it deserves mention that we've now completed a third consecutive record year, and we stay very optimistic. Also worth noting: our 11% increase in U.S. consumer came up against a 24% comparison, while Hawthorne's 39% gain was measured against a 64% comparison. I recognize there are clear questions that need answering. Where we stand on pricing, what's ahead for commodities, the surplus inventory sitting in the cannabis market, and how we think about allocating capital. Every one of those subjects will get covered, along with our views regarding fiscal '22. That said, I've now served 20 years as a public company CEO. And all too frequently, I've watched short-term matters commanding the market's attention and drowning out the larger picture. So I intend to direct the bulk of my time toward matters beyond our present results. Honestly, plenty of excellent developments are underway at the company at this moment. A number of them I'm unable to discuss with you, but they're genuinely thrilling. We're at a real turning point in our business — one that could change what this company looks like five years down the road. There's an opening here to build something stronger, to widen and deepen the competitive moat around what we do, and to hand a new generation of leaders the chance to shape this company as they see it, rather than through my eyes alone or those of my executive team. We also see today's market turbulence as an opening. When you're willing to step up in moments like this, you can capture opportunities that others simply can't, and you also get the chance to further strengthen your competitive advantages — and it's putting those advantages to work that creates shareholder value over the long term. The main thing I hope everyone comes away with today is a better sense of where this journey is taking us. Let me be straightforward: the group I'm actually addressing is pretty limited. To those on the sell side, I get why you need to fine-tune your models and pass along what you learn to your clients; we'll make sure you get what you require, though you aren't who these remarks are for. Short-term investors aren't my audience either. I won't get dragged down a rabbit hole involving our quarterly splits as they relate to commodity spot prices, or some bridge covering year-over-year SG&A. What I do want is to reach those investors who recognize the long-term opportunity that SMG shares represent. Let me lay out the direction we're taking and the reasons we believe our work will deliver value for shareholders. The key questions about fiscal '22 deserve a straight answer, and I won't dodge them — but instead of letting the P&L impact define the discussion, I'll treat those items as part of a broader view of how this company is operated. Still, reaching our destination requires a quick look backward. September 30 marked the finish of a 5-year period. Our strategic plan at the time rested on an assumption of a core business that was fairly mature, combined with enterprise growth of roughly 4% to 6%, and driven by quicker expansion at Hawthorne. Our aim was delivering steady shareholder returns of 10% to 12% through P&L leverage, share buybacks, and keeping dividend yield near 2%. On top of that, we established a 5-year objective for cumulative free cash flow of $1.5 billion. Every one of those targets was surpassed. We take pride in that, yet we also recognize the strategy has played itself out, since today's opportunities look different. We look different as well. So our next evolutionary step will mirror those realities. For the coming 5 years, we've identified 5 separate pillars of growth. 3 among the 5 pillars tie to the U.S. consumer business, while the remaining 2 connect to Hawthorne. To begin, we anticipate a greater degree of sustainable expansion from our current brands within the core business, mainly because we can connect with a fresh generation of consumers. Next, additional growth in our direct-to-consumer initiatives is available for the taking, provided we put money into people, brands, partnerships and infrastructure. Third, live goods continues to be a significant growth engine and an entry point toward a more direct bond with gardeners. For consumers, our objective hasn't changed: they should view us as a gardening company, not a gardening supply company. Fourth, if Hawthorne's future growth is to be supported, the commercial grower has to stay at the heart of all we do. That calls for further reinforcing our model, powered by innovation and technical solutions. And fifth, nobody doubts the cannabis industry will keep evolving and expanding. There's also minimal doubt that businesses bold and inventive enough to get in early on that opportunity could enjoy a first mover advantage. Creating Hawthorne demonstrated our readiness to act that way. And as I'll explain later, we plan to do so once more. While chasing these pillars, we're reinforcing our team. We're zeroing in on succession planning and making certain our ESG efforts are woven into operations while also being better grasped by our key stakeholders. Together as a team, and alongside our Board, we argued over whether to chase every one of these opportunities simultaneously; we unanimously concluded we had to, though we acknowledge that delivering on all these pillars demands we restructure and hand power to a new generation of leaders. Although nobody on the current team, myself included, has plans to walk away, virtually everyone on my team has reshaped their organizations. Achieving success in these initiatives demands a greater share of Mike Lukemire's attention directed toward strategy and execution in the business's fastest-expanding segments. He has restructured the organization so that every one of those pillars now reports straight to him. So what that means is he's passed most of the day-to-day running of the U.S. consumer business over to Josh Peoples and Dave Swihart — they're essentially serving as co-leaders of that unit. Meanwhile, on the corporate side, Cory has built up his leadership bench by recruiting people from outside the company. Denise Stump and Jim King have also reorganized their teams so they can support the business more effectively. And beyond all that, most of the acquisition candidates we're pursuing already have management teams in place that could make ours even better. If every one of those opportunities pans out, Scotts Miracle-Gro could be twice as big within 5 years. That's not really the goal, though. What we're after is smart growth, not growth merely for its own sake, yet the scale of the opportunity might be game changing. Let me quickly explain how we intend to deliver on these pillars, or rather, I'll discuss them through the lens of what we expect next year. Looking at the first 2 pillars together, we think the U.S. consumer segment is capable of delivering sustainable long-term growth of 2% to 4% each year. Under our prior strategic plan, we had assumed growth of 0% to 2%. If we're able to maintain growth at that elevated level, those additional 2 points bring meaningful P&L leverage along with better cash flow.

Jim Hagedorn

executive
#3

I should point out that the outlook we've provided for the coming year bakes in an assumption of growth that's either flat or slightly negative for the U.S. consumer segment. The thinking behind that is a presumed business reset once we're past COVID. To be specific, our plan anticipates that lower unit volume gets made up for through price. As you may recall from the call we held for Q3, we implemented about 5 points of pricing that kicked in during August. Over the last several weeks, our retail partners have been told about a second round of price increases that starts in January. Depending on which product line you look at, this more focused increase falls somewhere between mid-single and low double-digits. All told, our current expectation for pricing in '22 sits on the high single-digit side, and the aim is to offset what we're paying for commodities. We do think the sales assumption we've made for '22 represents a cautious approach to planning, yet the trends point toward something better. The reasons are as follows. During fiscal '21, consumer POS in units came in 6 points above 2020. Even more significant, that figure stood 21 points above fiscal '19, and it actually strengthened as the year went on. In the fourth quarter of fiscal '21, consumer volume, though it fell 7 points relative to the record set the prior year, ran 35 points above the equivalent stretch of fiscal 2019. What consumers are demonstrating is that lawn and garden occupies an essential place in their lives. However we slice the data, it shows they remained with the category and with our brands across this last season. October has carried those trends forward. It may be a fairly small month, but it provides an important close to the season, particularly across the Midwest and Northeast. In October, POS and units rose 4% versus last year's record, and were 42% above fiscal 2019. Once we're in the off-season, the POS figures won't reveal much to us until February arrives. And clearly, the extent to which we've held onto the COVID bump won't be known until next summer. Even so, I have confidence that the base we'll be growing from is significantly higher; we keep investing with that in mind. It's evident that millennial homeowners have turned into a demographic tailwind, and they're more than making up for baby boomers exiting the category. These consumers place greater importance on gardening than their parents did, and they also view the categories as more rewarding and purpose-driven. Should a 30-year-old couple purchase a home today and join our category for the first time, they could remain with us for 20 years or even longer. That time frame has to guide how we operate; we don't want our marketers worrying about whether they'll hit a target for Wall Street. Driving consumer engagement, brand loyalty, and market share is their job; and we intend to provide Josh Peoples and his team with the tools needed to accomplish that. The same applies to our direct-to-consumer pillar. That area is nearing 10% of our U.S. consumer sales and is only going to climb higher. When direct-to-consumer comes to mind, it extends far past selling items on our website. Additionally, it involves working hand in hand with the retail partners we have to back their digital initiatives. It also involves seeking out fresh partners capable of enhancing gardening's attractiveness and possessing their own online channels for us to utilize. Among our most brilliant and imaginative leaders is Patti Ziegler, who oversees our direct-to-consumer operations; beyond what I've already noted, she and her group have introduced native online brands such as Green Digs, knock-knock, and instead. Yet one of their biggest wins came through AeroGrow. Owing to Patti's guidance and the addition of our R&D and marketing strengths, we transformed a shrinking operation and increased its revenue threefold from 2019 to close to $100 million. From the very beginning, Patti has advocated for what our direct-to-consumer platform could achieve, and she keeps envisioning what lies ahead for this business. Achieving success in direct-to-consumer also demands upgrades to our IT and supply chain foundations. Dave Swihart, who was recently given a broader mandate covering both supply chain and R&D, is pushing us toward that objective. We must get better at delivering straight to consumers, particularly for areas such as live goods, where online opportunity is considerable. Not long ago, our direct-to-consumer initiatives were under the radar, but no longer. Though it's still premature to judge the full scale of this pillar's potential, it will play a major role in driving growth ahead. I hold the same conviction that our third pillar, live goods, will prove even more crucial. Live goods serve as the entry point to the lawn and garden segment, yet they've traditionally been extremely localized, inadequately marketed, and heavily commoditized. We think we can improve on that. We've made a strong beginning with Bonnie and its head, Mike Sutterer, and alongside Bonnie's co-owner, Alabama Farmers Coop, or AFC, we're exploring additional growth avenues that carry substantial promise. AFC shares our vision, just as we do, of building a nationally branded operation spanning multiple live goods categories. Jointly, we think we're positioned to serve gardeners and our retail partners better via innovation, marketing, and supply chain; we've already achieved enormous strides in strengthening the Bonnie business. Even so, we've barely begun to tap its full potential. The remaining 2 pillars concern Hawthorne. Chris will cover more ground on what's happening now, but I want you to understand I'm not fixated on Q4 sales or our Q1 outlook. I think Chris and his group grasp the present situation well. More crucially, I think they're steering through the market's turbulence while remaining focused on what's possible over the long haul. Should the market struggle for a few quarters, anticipate that they'll capitalize on it. We won't pursue sales for their own sake, but we will adopt a bold posture to further entrench Hawthorne and bolster its standing in the market; so anticipate, for instance, that we'll step up our innovation work. Last week I at last saw our new R&D site in British Columbia. It's incredible. I just got back from seeing field stations in Oregon, Florida, and naturally, Ohio. So what did I take away from that? The research we're conducting on hemp and cannabis is transforming the industry. Whether it's lighting, nutrients, or growing media, the point of our research isn't only to keep making our product lineup better — it's even more about helping growers achieve results that are both superior and more cost-effective. When it comes to plant science and the subtle details of indoor cultivation, nobody understands it the way we do. Not only is no 1 in the industry doing, what Hawthorne is doing, our rivals cannot even attempt to copy that approach. I'd suggest you remember that. We're also probably going to treat this stretch as a chance to ramp up our M&A activity; we remain disciplined when it comes to M&A, though the economics behind certain deals of ours have gotten more appealing as of late. A new subsidiary we recently formed, named the Hawthorne Collective, embodies the last pillar of our strategy. For months I've been hinting at the possibilities for putting money into emerging parts of the cannabis industry, and this marks my first chance to talk about that effort in depth.

Jim Hagedorn

executive
#4

It begins with the investment we made recently in RIV Capital, a publicly traded company headquartered in Canada that either owns or holds stakes in a group of cannabis-related businesses. Alongside the other significant investors at RIV, we hold a shared vision: to build a fully integrated operation founded on obtaining licenses for both cultivation and distribution. From that foundation, Roof can team up with some of the best-run brands in the cannabis space. Plenty of speculation exists about the chances for emerging brands to thrive as the market grows in categories such as beverages. Yet not enough attention goes to brands that already exist in traditional categories. This market is already valued in the billions, and the brands operating within it are confined to separate state-level silos. We have no doubt that as the market expands, there's massive upside for some of those brands to find success on a broader scale, and funding RIV demonstrates that belief. Because of our unique and deep knowledge in cannabis, we think we're positioned to win in categories beyond what we currently hold; however, right now we're unable to put money directly into those categories. In fact, we're not even allowed to take a direct ownership position in a business that can, but we are able to set up an option to own one, and that's precisely what our convertible loan to RIV Capital is. Over the near term, we don't anticipate any effect on our P&L from the RIV investment, and the capital deployed — $150 million — has no bearing on our capacity to put money into other areas or hand cash back to shareholders. Looking to the intermediate term, RIV might pursue additional capital infusions. Depending on the opportunities, we could have interest. I won't guess at how much we might put in. Honestly, it depends. Still, exactly as we did when we bought General Hydroponics, Botanicare, Gavita and Can-Filters, we're prepared to put money into things others may steer clear of, until the future becomes clearer. Should you be a short-term investor, this may not sit well with you. That's okay. Still, the upside over the long haul is real and sizable. Ultimately, should we convert our financial stake in RIV into equity — which is absolutely the goal — that could prompt us to reconsider the way our capital is structured today. Several of you have asked about spinning Hawthorne out as an independent public company. My position has been that we would only consider it for strategic reasons, never to chase a valuation, and nothing has changed there. Over the past year, we've put in work to understand what such a separation would involve, and my sense is that we could execute that kind of move if we concluded it was the right call. Let me be clear. We have no near-term plans to do this. Yet might it turn into a workable path forward? In my view, the odds are rising. Handing things over to Cory, I'd like to stress that my confidence in what we'll achieve soon matches my confidence in where we're headed over the long haul. Within the U.S., our consumer business is performing strongly, and buyers continue to demonstrate how significant this category is to them. Regarding Hawthorne, we still expect top line pressure through Q1. I trust our team's ability to work through it, and for the entire year we keep expecting sales growth. Thanks for bearing with me this morning, as I realize my prepared remarks went on longer than they typically do. Is the landscape tougher today than it was twelve months back? Absolutely. Do I feel great about where the stock trades at this moment? I don't. Even so, we're moving along a route toward creating a superior and more resilient company, and the surrounding chatter won't throw us off course. Earlier I noted that every one of the financial objectives tied to our prior strategic blueprint had been surpassed. What we're aiming for now is staying on a trajectory where investors keep gaining from the possibilities I laid out under our fresh plan, along with the pillars I've gone over. That shared conviction plays into why we chose to step up our buyback activity. During our previous quarterly update, I mentioned that $250 million had been set aside for this initiative. At this point, we anticipate increasing that figure by an additional $100 million, and our goal is to buy back as many of those shares as we can over the coming 2 quarters. We still have quite a bit on the agenda today, so I'll hand things over at this point. Cory, please take it from here.

Cory Miller

executive
#5

Thank you, Jim. I'll take a few minutes to walk through the major themes from our Q4 results, particularly on the sales and gross margin fronts. I'll offer some perspective on the guidance we issued this morning for fiscal '22; and in the middle of that, I'll hand it over to Chris for some color on Hawthorne. Beginning with the top line, as you saw this morning, sales growth across the company for the full year came in at 19%, which matched the updated guidance we gave a few months back. U.S. consumer sales outperformed what we had anticipated, ending up 11% versus the 7% to 9% growth we had expected. Sales came in at $3.2 billion, which is an increase of nearly $900 million compared with 2 years ago. A huge amount of praise goes to the supply chain team, whose execution made that expansion possible. The focused investments we've already made, and those we'll continue to make, in this area are going to be essential. Throughout Q4, consumer engagement remained exceptionally robust, and as a result our retail partners stayed just as involved. While sales for the U.S. consumer segment fell 28% in Q4, the comparison we faced was a plus 92% comp. Keep in mind as well that this year's Q4 contained 6 fewer days than the prior year's. If you account for that difference, the quarter's sales would have been down 23%. At Hawthorne, the calendar shift took 7 points off the quarter. Even though sales were down 2% compared to the prior year, once you account for the calendar shift, the segment actually would have posted a 5% gain on a like-for-like basis. And over in the U.S., Hawthorne's business saw growth exceeding 10% in Q4 of last year under that same comparison. Keep in mind too that Hawthorne was facing a tough comparison — a 64% increase during the equivalent period twelve months earlier. Looking at the whole year, Hawthorne's revenue climbed 39%, reaching $1.4 billion. That figure, as I mentioned, stood at $640 million back in fiscal 2019. So in just two years, we've more than doubled that business's sales, and every bit of it came organically. Turning to segment profit, Hawthorne brought in $164 million during fiscal '21, which works out to an operating margin of 11.5%. Earnings came in 46% higher than a year ago, and they exceeded 2019's figure by over 200%. Our stated aim, which we've mentioned many times, has been to find the right middle ground between expanding and becoming more profitable. The numbers, in my view, make that case on their own. Many of you are aware that I spent time as the finance lead at Hawthorne from close to when that business began, prior to coming aboard the corporate group in the CFO role. When you review what Hawthorne delivered, my suggestion to investors is to dig beyond the headline figures — even though the top-line expansion and bottom-line gains have been quite strong. The changes we've brought to the way this company runs are actually a stronger narrative. We brought together seven distinct companies, rolled out SAP, restructured our sales team, and built an R&D effort centered on cannabis that no one else in the world has. This team's work has been remarkable. I realize everyone is eager for details on where things stand right now. Let me pause here and turn it over to Chris Hagedorn for a bit.

Chris Hagedorn

executive
#6

Thanks, Cory. The specifics behind the figures I'll leave for Cory to cover, though I realize all of you want to know where the industry stands at present and how we're steering through it, so allow me to spend a few minutes on that. Clearly, some disruption is showing up in the market at the moment, yet we view it as short-lived. Our field sales team started picking up on indicators of a possible downturn in late June. By July, we had a clearer grasp of the problems, which let us pass along a portion of those observations during our third quarter conference call in August. At that point, we warned that Q4 growth would be considerably slower than what the rest of the year has delivered. Since then, a lot of you have asked whether this amounts to a repeat of 2018. That's not how we see it, and others agree with us. A number of you traveled to Las Vegas a couple of weeks ago for the MJBiz conference, which ranks as the biggest cannabis trade show anywhere in the world. If you attended, you witnessed for yourself that this industry isn't one that fears what lies ahead. Consumer demand for cannabis products keeps rising, and the market keeps growing. Regarding the present situation, what struck me clearly in Vegas was that the industry is getting more and more skilled at handling the turbulence that's unavoidable in a market of this kind. What's taking place right now is really quite simple. In California, far too much cannabis was harvested over the past few months, particularly by outdoor growers located in the northern portion of the state. Added to a robust harvest from the first round of crops earlier in the year, numerous growers brought in their second cannabis crop sooner this season over worries about wildfires, drought, and, for the legacy market, apprehension about stepped-up enforcement efforts. Too much product combined with comparatively low quality has driven wholesale cannabis prices downward. Still, that problem ought to resolve on its own once the present supply moves through the marketplace. Because the legacy market continues to be a major factor in what's occurring in California, the data available is limited, which makes it difficult to provide a precise answer regarding how long the existing oversupply will need to clear the market. That's the reason we're presently projecting Hawthorne sales to fall in the first quarter. Even so, the most critical single fact is that the end market for cannabis keeps expanding, and we anticipate growth resuming in the new calendar year. And practically nobody expects that fact to shift for the foreseeable future. Indeed, many high-end growers have shared with us that today's market troubles aren't affecting them whatsoever, and they keep thriving. One more key fact to keep in mind is that, in contrast to 2018, no regulatory obstacles are standing in the way at this time. Three years back, California really fumbled how it launched the adult-use market. That was by far the main thing dragging the market down at that time. Getting a license to run legally was next to impossible, whether you were growing or running a shop. The market in California today is still pricier and more tangled in red tape than what you see in other states, but it's a huge step up from where things stood before, and the legal side keeps expanding. A number of you are also asking if what's happening now will lead to some consolidation. That's an easy one. Of course it will; but swings like that are precisely what we'd anticipate. That's what played out in Colorado in 2015, it played out in Oregon once legalization arrived, and to some extent it will likely play out in California too. As a matter of fact, that's what we're watching unfold in Oklahoma at this moment. As with a lot of new markets, Oklahoma burst onto the scene with rapid growth and likely ended up somewhat overbuilt. So we figure there will be a pause there before things pick back up. We've said to you many times through the years that choppiness is something this industry will probably experience now and then. An oversupply of cannabis isn't new to this industry, and let me be clear, it won't be the final time either. What matters for Hawthorne is that we stay the course. Over the long haul, growth will come. That doesn't concern me. What I care about instead is making certain we do all that's required to put distance between us and our rivals. Jim already mentioned that our innovation push won't let up, and that push, incidentally, extends well beyond merely launching new products, which takes me right back to the MJBiz conference held a couple of weeks ago in Vegas. As with most big trade shows, COVID forced MJBiz to be canceled last year; so it's been more than two years since we've had the whole industry gathered in a single spot. What came through clearly to us, and honestly to just about everyone we spoke with, is how far Hawthorne has progressed across those two years and how much separation we've built from the competition. Our whole method of selling has been overhauled, and that shift is still underway. We've introduced new offerings that deliver better outcomes for growers, boosting yields while also bringing their operating costs down. And we've leveraged innovation to assist us in more qualitative areas, such as creating the Hawthorne Social Justice Fund, housed inside our corporate foundation. I get why you all have to raise questions about the slowdown in our growth rate, but I'd encourage you not to overlook the larger picture. Without question, we're the obvious leader in this industry. Without question, our competitive advantages are one of a kind, and without question as well, the cannabis industry still has a great many miles of runway in front of it. As we turn our attention to fiscal year 2022, minor obstacles don't concern me. What actually energizes me is the prospect of driving this company even farther and staying at the forefront of a sector that is still set up for growth lasting many years. With that said, Cory, I'll hand things back over to you.

Cory Miller

executive
#7

Thanks, Chris. Now let's head further down the income statement to the gross margin line. As is the case with just about every other consumer packaged goods business, we've kept facing headwinds from rising commodity expenses and distribution costs. That said, the margin rate's year-over-year movement in Q4 needs a bit more context; during the fourth quarter of fiscal '21, our adjusted gross margin rate stood at 17.4%, versus 24.3% in 2020. Company-wide sales during last year's Q4 climbed almost 80%. So fixed cost leverage in what was a comparatively small quarter produced an enormous gain in the margin rate. When you set the Q4 gross margin rate for '21 against '19, the gap turns out to be merely 100 basis points, and that gap reflects a mix of segment mix along with greater commodity costs; looking at the full year, the gross margin rate fell 270 basis points, landing at 30.3%. The roughly $85 million year-over-year rise in commodity costs, essentially all of it in line with plan, stood as the leading cause of that decline, with higher distribution costs coming next. As you're aware, we held off on adjusting our prices until August in the U.S. consumer business this year. That left us with only limited room to counter commodity inflation across the first 3 quarters of the year. That picture is going to shift considerably in fiscal '22, and I'll go into more detail on that when I walk through our guidance for next year. Greater volume allowed us to generate better fixed cost leverage, and conversion, which helped counter the commodity cost increases. SG&A finished 2 percentage points lower in fiscal '21, at $743 million; during the quarter it dropped 21%, to $161 million. Reduced variable compensation was the biggest factor. In addition, back in Q4 of 2020, we tapped some of our sizable earnings upside, to sharply boost our yearly contribution to The Scotts Miracle-Gro Foundation, something we didn't do again in fiscal '21. Interest expense ran $5 million above the prior year in Q4. yet was basically unchanged for the full year. Keep in mind, we put out $900 million of bonds during the year's second half, which pushed the quarterly figure up. Turning to the bottom line, adjusted net income, which leaves out restructuring, impairment, and onetime items, rose 28%, reaching $528 million, or $9.23 a share. That's only $0.01 short of a $2 per share gain in one year and over double the $4.47 a share we delivered in 2019. That EPS figure sits at the top end of the revised range we established in early June, and represents a significant achievement given the tough comps, and a few of the cost obstacles we've needed to get past in the year's second half. We're clearly happy to take any questions you have about our Q4 or full year results; but rather than devoting more time to those specifics, I'd like to shift direction and share what we're thinking about Goal '22. As this morning's press release showed, you'll see company-wide sales next year at roughly flat to plus 3%. We're basing this on the U.S. consumer segment coming in somewhere between flat and down 4%, plus Hawthorne expanding between 8% and 12%. Those ranges don't include any possible effect from acquisitions. Within U.S. consumer, our planning assumption for the year ahead is a high single-digit drop in unit volume. About half of that decrease should come from softer shipments during the first six months. Keep in mind that Q1 of last year rose almost 150%, because retailers were scrambling to restock shelves that had run low. Given that retail inventory today is still above where it stood a year ago, a similar initial load-in probably isn't going to happen again; for planning purposes we're also building in modest decreases in consumer takeaway for fiscal '22, largely because of the tough comparisons we're up against in the first half. Jim mentioned earlier that consumer POS has come in above our expectations lately, and in fact has been positive through the fall season; leaning in to satisfy stronger consumer demand is easy enough should it materialize, but assuming a small decline is the sensible approach. Pricing ought to cover most, and possibly all, of the unit volume decrease we've planned. Some pricing benefit should show up in Q1 thanks to the August price increases, with the rest kicking in during Q2. Turning to Hawthorne, our plan assumes 8% to 12% growth for the full year. That's because we anticipate ongoing pressure in Q1. Per Chris, pinning down the industry's present inventory supply challenges with precision is difficult, though we hope growth resumes at some point in Q2. Now let's discuss gross margin. On a full year basis, we anticipate the gross margin rate falling 100 to 150 basis points. We're cautiously optimistic that our pricing actions will counter the commodity pressure we expect. Even so, roughly 65% to 70% of our costs should be locked in once the calendar year ends; that leaves us with some exposure should costs rise beyond the planned increases we've assumed. Lower fixed cost leverage and segment mix will be the 2 largest pressures on the rate next year; we'd anticipate some leverage from SG&A, which means this line could land anywhere from a 6% year-over-year decline to a slight uptick, perhaps 2%. SG&A has no significant moving parts, and we stay committed to investments that we believe will drive the business, not only in fiscal '22 but in the years ahead. Beneath the operating line, interest expense ought to run about $25 million higher, reflecting the full year effect of our recent bond offering. Our guidance likewise assumes no offsetting earnings impact from acquisitions, which is a fairly conservative place to start. Everything together produces an adjusted EPS guidance range of $8.50 to $8.90. I'd also like to spend a moment on cash flow. During the fiscal year that just wrapped up, free cash flow — which we define as operating cash flow less CapEx — totaled $165 million. That figure is admittedly low compared to what we've seen historically. Three primary factors explain why it dropped versus the prior year. The first involves variable compensation: it was earned during fiscal '20 but didn't get paid until fiscal '21. The effect of that was roughly $60 million. The second factor is that our CapEx rose by roughly $45 million. The third is that inventory came in $500 million above fiscal '20 levels. Although we covered most of that build during the year, we relied on our vendor partners to a greater degree than we have previously in order to secure stretched-out payment terms. Turning to fiscal '22, our target is free cash flow reaching as much as $300 million; we anticipate CapEx will rise once more, and we likewise anticipate that inventory, though unchanged in unit terms, will be larger in dollar terms given higher costs. We need these investments to keep delivering the service levels our customers require, and that matters more than anything else. Regarding inventory specifically, though, we currently feel very well positioned. Across both U.S. Consumer and Hawthorne, we think certain rivals are going to struggle to keep up with demand. Within the consumer segment, we anticipate the market will experience short supplies of grass seed along with sphagnum peat moss, which is the critical input for growing media. We don't anticipate those problems affecting us, and we don't anticipate any difficulty getting our customers to suitable inventory positions either. Prior to opening the line for your questions, I want to share one last thought. Jim's take matches my own. There are numerous moving parts at present, plus a number of active initiatives that might force us to revise our outlook as the year unfolds. Yet even if — unlikely as it seems — not one of those efforts pans out, I think this business stands in an excellent position. The pressure we're experiencing on the cost of goods line aligns fairly well with what you've heard reported by other companies during the last 2 weeks. And exactly as promised, we've moved aggressively to remain in front of every one of those pressures and safeguard the business's profitability. Considering how far this business has traveled in so brief a span, it's difficult not to feel optimistic about our current standing. With that said, I'll hand things back to the operator so we can begin taking your questions.

Jonathan Andersen

analyst
#8

There are plenty of things I could ask about, but I'll begin with Hawthorne. I appreciate the details you gave regarding California, and I understand what's happening there. What I'd like you to address is what you're observing across some of the more recently legalized states — over the past 12 months especially, adult-use cannabis has become legal in a number of places, and a few of those states are fairly big, so the overall count of people residing where adult use is legal has climbed substantially. My impression is that demand from those newly legal states hasn't really shown up for you yet. Can you give us some kind of update on where things stand? And when do you think that will begin to take effect?

Chris Hagedorn

executive
#9

Jon, this is Chris, yes. You've got that exactly right. A lot of states came through. And when you mention heavily populated states where adult use has been approved, I take it you mean places such as New Jersey. We've always preferred to give you folks — and honestly, ourselves too — roughly a year, in our view, starting from the point of passage, since that's when we figure the market will start to take off. And although I'd call that a sensible projection for most states, you have to temper it with the fact that everything hinges on state legislatures putting the regulatory structures for these markets in place; and in a state such as New Jersey, that process has dragged on far longer than anyone anticipated. To illustrate, New Jersey had a large batch of social equity licenses — adult-use cultivation licenses — that were meant to be awarded back in 2019. Those licenses only got granted 2 weeks ago. That's just one illustration of how sluggishly that state has acted to actually approve what the voters requested. And in that state, once those adult-use licenses are operational under medical, they won't be permitted to sell into the adult-use market until a year has passed. So those folks have to construct their medical grows, get them running, and operate for at least a year before they qualify for adult-use. So despite adult-use having passed there, we've encountered regulatory obstacles that truly drag that timeline out for us. So we anticipate New Jersey will begin to take off. We're already seeing a few very early results, but it remains a very small state for us; so once again, a year has always been our rough figure, yet it appears that could be somewhat optimistic in certain Northeastern states that basically lack any existing framework and are still working out the details.

Jonathan Andersen

analyst
#10

Thanks; that helps a lot. I appreciate it. Now, for my second question, I suppose I'll keep it at a higher level. Jim brought up live goods multiple times as an entry point into lawn and garden. It's 1 of the 5 pillars you laid out for growth over the next several years, so could you just give us more detail — what have you managed to do in live goods so far, and what have you achieved? Looking ahead, what remains undone in live goods that you'd like to accomplish, something that would add to your earnings growth, whether that means doing more with Bonnie, expanding the relationship with AFC, et cetera?

Jim Hagedorn

executive
#11

Okay, I'll kick things off, then pass it over to Mike, who I consider the real architect behind this strategy—and I'm fully on board with it. Let me just cover what we've accomplished so far. This year, I believe we've taken some steps into private label and picked up quite a bit along the way. I'll let Mike get into that, since it ties into where we're headed. But first, let's focus on what's already been done. We acquired—or rather formed a partnership with AFC around the Finest brand, which is honestly the sole national brand in live goods, and that's Bonnie. We've been working alongside them to genuinely start making things more professional. It isn't as though their conduct was unprofessional. Still, we've picked up plenty about the way we'd prefer things to work, and Mike has really spearheaded that effort on our end. If you ask where we're headed, the answer is that we'd like to play in those other categories while keeping the same principles — branded, national, and able to leverage scale. Even so, let's keep in mind what drew us in at the start. What we're telling you now, and it holds true, is that we simply have no wish to be, in effect, a lawn and garden cannabis business. For people who garden seriously, everything begins with plants, along with the psychology behind why someone desires a garden. There's genuinely a great deal in there that benefits us, but our focus is on plants, which we see as a sector poised for strong growth. Take what's happening right now — in our view, it comes down to younger buyers who aspire to homeownership. That's quite a shift from maybe five or six years back, when the narrative was that everyone would flock to urban centers, buy a condo, and skip having a yard. I think we feel very differently than that now; and young people want their own homes, there's a gigantic bubble of kind of our kids, who are at that phase now where they're buying homes and having kids, and the dog or whatever. And that data we talked about a little bit, they want to garden. So when you take a look at our core, and you figure we believe it's possible to roughly multiply that by 2 — which, honestly, I'm not sure, that isn't saying much. Mike and I go back and forth on this, whether it's 0% to 2% or 2% to 4%; yet what we're witnessing in live goods is a growth rate that comes in at a minimum of 2x that figure. That, then, is what drew us to this business, along with the notion of becoming more engaged in, in a sense, the fundamentals of gardening, and the brand aspect of things, which Bonnie is delivering to us. So the real question becomes: what have we taken away from all this, and Mike, how would you add to the craft?

Mike Lukemire

executive
#12

Okay, so a nationwide network — that's something Bonnie delivers, but also the level of sophistication. Honestly, aside from Bonnie, you won't find another national brand out there. There's so much fascinating genetics and activity we're able to introduce into the market, and our view is that we connect the consumer's solution with the rest of our offerings, so the consumer gets a stronger shot at succeeding and taking pleasure in gardening. So everything gets linked together. Succulents are on our radar. We're looking at — succulents are actually something we're doing, and we've grown and moved into some color as well; Miracle-Gro flowers are available at Lowe's. So our focus is on delivering that nationwide network plus supply chain infrastructure, which is likely the weak point for any grower trying to supply those products across the country. And then also grow further in direct-to-consumer and get those products into that channel.

Jim Hagedorn

executive
#13

So what portion of your schedule is being devoted to this, Mike? I mean, the logistics chain involved in bringing it to the state you're aiming for?

Mike Lukemire

executive
#14

At this moment, it's likely around 25%. So there's genuinely no — what I mean is, we have brought companies together. Those systems need to be merged. And if you think back to where Scotts stood for me 26 years back, it was truly a supply chain operating on its own. What we're doing now is truly making the supply chain of the live good companies national, and genuinely making it work better. And then there's the branding, along with the marketing. And I'd say indoor is in fact a massive opportunity; it's genuinely underdeveloped; therefore we want to make that simpler for consumers.

Peter Grom

analyst
#15

So, I've got a handful of things about Hawthorne. Perhaps to kick things off, Jim, you mentioned there's more openness now to splitting Hawthorne off from the older operations, and I realize you said that isn't what you're anticipating in the short run, but could you possibly give us some insight into what's behind that rising conviction that this might be something you'd look at? And then, what would really have to happen for you to go ahead and actually do it? That's all from me.

Cory Miller

executive
#16

Man, I could talk about that 1 forever. Let me begin by talking about how accepted Hawthorne is inside, you know, the broader SMG universe. And I believe I've likely shared this with you folks previously, I think Chris is, I think he was always sort of a hesitant counterpart. And I think it's — I'm not sure how many years, Chris, you've occupied this role at this point, how long?

Chris Hagedorn

executive
#17

Seven to eight years.

Cory Miller

executive
#18

Greater longevity for dogs. If you examine our supply chain efforts and innovation work, we aren't truly pushing science forward. What we do — and additionally serving as a cushion during problematic periods such as 18, when Scott's scale proved genuinely valuable. So Hawthorne occupies, I'd argue, quite an advantageous position, and I'd describe it as likely extremely synergistic. Thus, regarding this matter of separation, I'm not claiming you'd encounter dissynergies, yet I believe it would need sufficient strategic justification that — well, Chris is agreeing, there would be some; however, I think certain arrangements might be established to largely reduce that. What's my motivation? Because I see possibilities involving similar-minded partners out there, and that's significant. Also, Peter, I'm uncertain whether we've previously met. I don't — if we have, my apologies; but perhaps you aren't very familiar with me, and frankly I'm simply not suited to being a junior partner. In our past transactions, we've operated as what we term a respectful minority interest, since that's roughly the level folks will accept. Many parties we'll engage with going forward — this is confidential discussion about future plans — I believe they have no desire to divest their companies. Might they take part in something that generated substantial value and grew into something meaningful? I believe the response is affirmative. Would they essentially align with the Allied Military, or whatever label you prefer? Yes, they would. And — considering the financial figures at stake, pursuing this over the long haul while occupying the role of a comparatively minor partner strikes me as difficult. Beyond what Hawthorne fundamentally represents, our offerings include management framework, capital, and entry to public markets, covering both equity and financing. There are simply numerous things we bring, and securing a genuine place at the table — in my estimation, the dominant player within this industry is Hawthorne, provided the correct structure. I'll express my own perspective, since my management team consists of my partners. There's a Board of Directors I must navigate alongside my family, and I believe I could envision Hawthorne contributing despite how appreciated it currently is here, in order to assemble the proper structure. And I believe that's what it delivers, and I don't think we've been harmed by acknowledging that having this cannabis operation embedded within a consumer lawn and garden market or business isn't particularly tidy. I believe, particularly back when the share price was elevated, I felt it was appropriately valued — Hawthorne's worth plus Scott's worth put together — and it seemed better than the way things look at this moment. Still, it seemed right. And in no way did I view it as a drawback for us. I do believe there are folks who would put forward a case, and I have some sympathy toward that case, though that doesn't mean I'm in full agreement with it. Suppose it's tidier for those looking to put money into, roughly speaking, the cannabis sector — above all if a move were as strategic as the one I picture — to not have it tangled up with, roughly speaking, the lawn and garden operation, which grows more slowly and is likely a business with stronger cash flow. So I could put forward a case that, that, that would be the correct course, or at least could be. We've also devoted no less than — let me say — the past 18 months to ensuring our financials are severable, the kind that can be financed in, roughly speaking, a public manner. And we are — I'm not certain, I was speaking with Ivan Smith, a week, 2 weeks back, and said we've arrived, correct? From a financial and legal standpoint we've arrived, where they can be severed; and my recollection is what he told me is within a month or 2, and I believe that's right. So once more, there's no urgency about it. Yet I do believe that — and this matter that arose regarding, roughly speaking, the East Coast in Jersey — I consider these extremely valuable opportunities; and I consider the dollars — and keep in mind, these are — I won't attack the United States government, other than to say <<inaudible>> is a piece of ship. It's absurd that the United States government earns more from public marijuana than the business owners who have put money in behind them, and that has to be corrected. And we're engaged in D.C. working to solve that. But on a before tax basis. These are substantially profitable businesses in their early years. And so I believe that if you examine what these businesses are worth, you can reach a point where you're talking about real money, and to, roughly speaking, handle balance of power matters — that's where I arrive at saying Hawthorne truly must be a component of that. And so I — hopefully, that addresses the question of — but I don't believe we're on the verge of a deal. However, if you happened to be 1 of my brothers, sisters and they asked, when do you figure this might occur, I would answer a year or 2 years, something along those lines, and I wouldn't be taken aback. And 1 final item, I'm not sure I've ever done a call where my son had a speaking part. Speaking as his dad, I feel quite pleased and proud that my older son is here beside me at the table. If I were making the case to all of you, I'd tell you he's prepared to take the reins. He might even be better at this than I am. So the main focus for us at the moment is making certain we grasp the roadmap we're building alongside some other folks for how this moves forward, and then assembling the management group that can genuinely back that business. Mike, myself, and the Board are dedicating a great deal of time to it. That's a fairly candid and honest response, all right?

Peter Grom

analyst
#19

No, that helped a lot. But perhaps for Chris, I was hoping to hear your perspective regarding Hawthorne's cadence looking ahead to fiscal '22. Could you perhaps assist us in grasping how large the negative pressure will be that you expect during Q1? What makes you confident it will bounce back so forcefully and reach that high single-digit, low double-digit objective for the year? Does your guidance contain sufficient conservatism? What if the underlying trends need more time to get better? And then just — I realize there's a lot packed in here, but regarding that Oklahoma remark. Could you perhaps help us grasp how significant Oklahoma is for Scotts or for the wider industry?

Chris Hagedorn

executive
#20

Yes. No problem. So Oklahoma has turned into a fairly material state for us. We observed growth of more than 1,000% there in that state across the last couple of years; and honestly, it was a state we'd been discussing internally as one we needed to ready ourselves for somewhat for a fallout in Oklahoma, simply because you cannot see that sort of growth indefinitely; and you witnessed comparable growth in states such as Oregon, back in 2017, which resulted in end product saturation in those states, and the fallout that followed which we handled a few years ago. To repeat what I said earlier in my prepared remarks, my sense is nobody anticipates a swing of the same size here, since — as I noted — back then there were regulatory and structural problems that made the excess inventory worse. You don't see those conditions in this case. As for why we feel good about this product moving off the shelves: I was in Vegas a few weeks back. A number of the analysts were there too, I realize, and I talked with quite a few people — sharp individuals with many years in this business. Right now I'm referring to actual cannabis industry veterans—not the corporate types who, like us, had to earn their place—but genuine cannabis operators. They told me, and this isn't meant to alarm anyone, that this represents the largest surge of finished product the cannabis sector has ever witnessed. I believe that's likely accurate. What makes me feel assured about this is that we're dealing with a perishable crop—it can only remain viable for a limited time. And, as I noted during my prepared comments, this is an effect we're clearly observing, and it's hitting the middle and lower tiers of the market far more dramatically than the upper tiers. You're hearing from plenty of premium cultivators. Among licensed growers at the high end, the amount of cannabis they're producing is at record levels. The retail prices they're getting are the best they've ever been, and whatever they can produce, they sell. Let's make sure everyone understands: this group is essentially the core of our customer base. These folks grow top-tier cannabis indoors. Because of that, we feel pretty confident this will get worked out — my guess is in the first three months of the next calendar year, meaning Q1, the first quarter of '22, is when we expect it to be resolved. Now, we've made mistakes in the past. I believe our intelligence on this is superior to anyone else's, honestly, and that covers our rivals. And I'd add that we have more hands-on experience in this area as well. Since 2018, Cory is truly the sole person on my leadership team who has departed, and he transitioned into the CFO position, collaborating with Jim. Our group has witnessed this type of market dynamic previously; we recognized what was unfolding when we saw it approaching, and we understood how to get ready for it to the greatest extent possible. So I have faith in the figures for the entire year. Naturally, they lean toward the back half — the third and fourth quarters; but once more, we're quite confident, the excess supply will get resolved. And once that happens, we will be in a stronger position than anyone else to capitalize on the market.

Bill Chappell

analyst
#21

I'll attempt to be brief. To start with, regarding your comments on Hawthorne and M&A, could you walk me through the thinking there — I mean, you've got a fairly wide product portfolio, and nearly all the deals you've completed or disclosed over the last twelve months have been quite tiny. I get that valuations look better these days. Still, it seems like a lot of trouble if the outcome is acquiring 300 separate $10 million businesses rather than just growing it organically; so please help me see why that approach — what makes it logical compared with, and this is sort of part two of my first question, why you didn't buy back stock during the quarter instead of doing so later on?

Jim Hagedorn

executive
#22

So should I — the buyback piece leaves me somewhat taken aback. — let's briefly address the M&A pipeline for Hawthorne, leaving aside the Hawthorne Collective or what we refer to internally as Apollo, since those are pretty distinct. Bill, you've been here a long while. I'd say we favor, on the consumer side, what we've always termed close-in adjacencies; these are companies and, given the Sunlight connection, we see chances in distributed products that we already grasp, that we already market, and that we know would generate very substantial IRRs if folded into our supply chain. And I'll add that in the cultivation sector, with full respect to the numerous wonderful individuals out there performing that work, folks tend to remain loyal when something is effective. Consequently, there exist branded companies where persuading people to switch isn't as simple as it appears, and where substantial chances and synergies exist, and we're able to purchase at a reasonable price. Then we apply those synergies to the company, and if I walked you through them — which I won't do at this moment — you'd essentially respond, "Oh hell, yes, you should do that". Nothing thrilling. Now, let me return briefly to LED lighting. Three years back, LED lighting was a segment that barely existed at any meaningful scale. As of today, it's our biggest single category. Moreover, well over 50% of our lighting dollars now come from LEDs; and I'm telling you this is — this is entirely driven by innovation, where I believe, alongside Mike and his R&D team, Chris and his people, in identifying the need, Mike Sutterer from Harvard, in crafting a strategic justification for the Gavita business rooted in distinctive and significant innovation; and so here's a business we built on our own; we created a category on our own. And it's expanding. And right now, we're substantially backlogged on our LED lights; so this is a space where, with more components, we'd be moving more products — and not by a small amount. To answer what you're asking, we're pursuing both paths at once—creating things in-house while also innovating, right? When an opportunity sits really close to what we already do, we have the option to simply acquire it, and Mike and Chris, along with their teams handling the supply side, are able to take care of that work, and beyond that we can direct our R&D resources toward it. The financial logic behind that strikes me as quite sound. If I walked you through each individual deal, your reaction would be, yes, I'm with you on that. So Chris, I don't believe you need to jump in at this point unless you'd like to.

Chris Hagedorn

executive
#23

Yes. No, I'd like to. Regarding those smaller acquisitions we completed not long ago, they are Riso Flora and HydroLogic. Those transactions are more about, in Riso Flora's situation, being extremely near, as Jim put it, in terms of adjacency. And what I mean is, we're discussing closeness from a category standpoint as well. The Riso Flora site located in Santa Rosa, California, actually has a shared fence with the legacy General Hydroponics site, which remains our primary facility for producing liquid nutrients. They are adjacent properties — their immediate neighbor. So that was one where our familiarity with that team was quite strong. The product appeals to us greatly. The brand appeals to us greatly. We greatly appreciate their capacity to genuinely gain marketplace traction, and no integration could have been simpler for us, since we already were neighbors right beside each other. I mean actual, physically adjacent neighbors. As for HydroLogic, that transaction traces back to our initial acquisition of General Hydroponics, when I spoke with Ross Haley, then serving as CEO of GH, during that deal and asked, "Hey, Ross, where should we head next?" He provided a lengthy roster of brands, the majority of which we have since purchased. At the very top of that roster was HydroLogic. Completing that transaction required some time. But that brand truly occupies a unique position within the reverse osmosis water filtration subcategory. You can scarcely find a commercial growing operation that lacks a HydroLogic system on its premises. Their network of industry contacts and relationships runs extremely deep and encompasses several called features where our own connections were limited. So for us, that was one that strategically had always been on our radar; reaching it required a few years, yet we simply — that transaction stayed in our minds. And I'm truly, truly pleased we have completed it. The team working there is outstanding. And throughout the recent months of integrating these businesses, performance has exceeded what we anticipated, even within the current marketplace.

Jim Hagedorn

executive
#24

Okay, so the last thing I want to touch on is buybacks. That shareholder-friendly strategy we rolled out — I think it came out of what we called Project Focus or something like that. We laid it out to everyone: we simply aren't seeing many attractive acquisition targets out there, so the plan was to return capital to the folks who own the company. What I think you're picking up on during this call is that we're not in that spot anymore — that's the shift — and this is what I mean when I say the strategy didn't exactly have an expiration date, but the landscape around us has moved, whether that's live goods or direct-to-consumer. Those pillars I keep bringing up are where the opportunity is, and we're building the organization around them, which lets Mike keep on top of all of it, and they all report in. But each of them has growth rates we believe in, and meanwhile we've got this incredible core business — slower growth, lots of cash generation. And don't forget, that $165 million, plus $500 million in inventory, plus CapEx, plus roughly, I don't know, $700 million in cash flow during '21 before those adjustments — so it's a genuinely fantastic business. The other businesses, we believe, are fairly clear-cut, and they grow faster. That's essentially why we're pursuing this. And it's why we've basically come out and said we need to fold in some acquisitions, and beyond that, looking at the Hawthorne Collective opportunity, we want to put money there too. That's really the reason we concluded that giving cash back to shareholders remains a key piece of what we do, but it isn't the only piece. A lot of what Cory and I try to weigh is: what's the proper level of investment in the business? Right now there's just so much opportunity. And I'm genuinely hopeful the United States doesn't get in the way. I don't know — I've got my eye on the FTC. God damn it. But what.

Cory Miller

executive
#25

I’d just like to mention that if we rewind to last year, the stock price was significantly greater. The way we were planning to give value back to shareholders was leaning more toward something in the vicinity of a dividend rather than repurchasing stock. Move forward to 4 to 5 months back, and the share price was much higher. During Q4, we did repurchase roughly $40 million worth of shares, so it’s not as if we had stepped away from the market. As we head into Q1 now, we feel increasingly at ease with the position our Q1 is in and the results we’re witnessing in the market. We believe we’re able to participate in the market through share buybacks at 2x to 3x that amount, and we’re comfortable doing so.

Andrew Carter

analyst
#26

I suppose what I wanted to ask is this: since the midpoint of your guidance for next year implies gross margin will fall 430 basis points from where it actually peaked earlier in this fiscal year, on a trailing 12 basis, can you help us grasp how GM will trend across the year as pricing offsets inflation? That remark about pricing running ahead of inflation — did it refer to the whole year, or was it something expected to occur at some point? And one last thing, just so we get a feel for how much further mix could drag things down: where does Hawthorne's margin sit right now? And where do the own brands sit? What's your penetration?

Jim Hagedorn

executive
#27

Look, I want to begin, because thank you for posing that set of questions. I was over in fitness this morning alongside Ivan, and I said, I'm in a mode of disavowing the budget, or at minimum the expectations we're putting out there. I do want everyone to grasp how and why we've sort of spoken to you the way we have today. And I think it's probably helpful then. When it came to setting the budget for the upcoming year — I think Cory would describe it as us looking at roughly neutral operating '22 against '21. My take would be that we looked at — and both statements hold. We looked at what the street was essentially putting out there as a figure for expectations for Scotts for next year, or the year we're currently in. And we constructed a number that — I don't know, let's call it a quarter above what we perceived as roughly consensus, which seemed like a decent starting point. Honestly, it's a fairly negative number for us; and from there, we began constructing an operating budget on that basis, which said, if things are that bad, and I don't anticipate they will be. This is the point I'm trying to convey: can we still — can we construct a budget that hits that number, roughly your consensus plus, let's say, a quarter. And still finance the things we want to finance and be responsible in how we operate our business. And I think this reflects Cory's contribution to his first budget cycle with us in this role. I really turn to Mike to say, it's just killing you, because I see budgeting as a fairly corrosive process, honestly. I really don't enjoy it very much. I recognize it's necessary, but it's fairly corrosive, especially when you make inputs like that. And Mike was fine with it because I think it sort of forced this issue of asking, are we putting money into the things we believe will drive the business? And can we ease up on some of the other items, and still make the numbers work, if the numbers are as bad as the ones we're building from. And we arrived at, I think, an agreement on that. And that's what shows up in the way we communicate with all of you; however, the figures I have, along with the ones Mike has, sit considerably above that; so I simply want everyone to sort of — whenever I make remarks along these lines, folks panic, and everyone understands the point that — this amounted to a budgeting workout. What we're doing is establishing expectations, drawing partly on where all of you stood, and partly on this quarry-related perspective of, is it possible for us to at minimum match the operating results achieved a year ago; and then how does that align with the approach Jim prefers for handling the investment community. As we move through the year, without getting ahead of ourselves, we begin offering greater visibility into the upside. With luck, that upside exists. That's essentially how we arrived at these figures. So I genuinely believe that when you pose your questions, please recognize this isn't a situation where we are bound absolutely to those figures. What binds us is a budgeting exercise, one that lets Cory feel comfortable that he hasn't stretched too far on costs, and that Mike senses he's directing funds toward the areas he cares about, while we avoid making promises to all of you that we can't keep. All of this forms part of how things operate around here. This year, yesterday I had a brief Board meeting to review these matters. During that meeting I wanted to kill myself, given what we were presenting to them, which resembles what we're presenting to all of you. It left me feeling down about the business, yet honestly I feel truly great about the business. Mike and I are dedicated to figures that are much higher. So I think when you pose your questions, please try at minimum to view things through that kind of lens. Cory, I'll now turn it over to you for the actual questions.

Cory Miller

executive
#28

Sure. I'll address the two items you raised. On the total company margin rate, our guidance was for a decrease of 100 to 150 basis points. When you break down what's behind that, segment mix plays a role — since Hawthorne is expanding at a quicker pace than the U.S. consumer business, an enterprise-wide reduction in our margin rate is just going to happen naturally, purely because of the margin rates of those 2 businesses. That accounts for roughly half. And should units land where we planned, meaning that decline, some deleverage will hit our margin rate. As Jim mentioned, all of us anticipate units coming in above that. But based on the plan we've established, deleverage might occur if units arrive lower; and regarding your point about pricing versus cost, those two essentially cancel each other out; so when you examine the margin rate, pricing and costs cancel each other out, and we still have some buying to complete during the remainder of next year. Think of where we'll be locked at the end of the calendar year — we're roughly 1/3 exposed. So risk exists there, or opportunity, depending on marketplace developments, for costs to shift from where they sit in our model today. And finally, on Hawthorne's EBITDA, you asked where Hawthorne's profitability stands; we're planning for roughly 500 — sorry, a 50 basis point gain year-over-year. So we remain on the path we've been following, working toward a total earnings percent of 15%, and we keep moving down that path. We saw solid improvement in '21 and anticipate roughly 50 basis points in '22.

Andrew Carter

analyst
#29

All right. I realize this might be difficult to respond to, but you brought up that some of the crop got pulled forward during the outdoor season in California, and I gather the upside there is that the crop in October is particularly bad. Could you put numbers to how the earlier pool — meaning, for example, not making sales to growers in August and September — may have dented the figures, and which product lines that might have affected, nutrients especially? That way we can consider a second-half headwind that weighed on this year and could come back next year?

Chris Hagedorn

executive
#30

Yes, of course. I mean, look, you already made that point. The impact of this downturn has landed much harder on our consumables segment than on hardware. Nutrients, growing media, and several other categories have faced significantly more downward pressure. To me, that signals operators are tapping the brakes, letting existing inventory sell through instead of spending a lot of effort pushing additional product into a market they already know is basically stalled. Meanwhile, on the higher-priced hardware side, things like lighting, dehumidification, and water filtration — infrastructure-type equipment — we're continuing to see genuinely strong market adoption for those products. Also, demand is sometimes greater than what we can supply, largely because of interruptions in the supply chain, especially for lighting. We expect all of that to settle down eventually. We continue to observe construction of new facilities, which signals to us that they will open. Once they do, they will purchase our nutrients or growing media—categories that showed outstanding growth through June and July. So the latter half of the year is fairly packed with substantial nutrient and growing media revenue; however, whenever we introduced new hardware or infrastructure offerings, those sold out. Last year, I was pretty vocal in touting the new Gavita LED light, which back then was the debut LED offering from us. Within Scotts Miracle-Gro, that became the biggest single launch ever recorded when measured in dollars. This year, our latest LED light surpassed that milestone. From our partners at Quest, we're moving more dehumidifiers than at any prior point, and that includes some genuinely thrilling, quite pricey, advanced units spanning a wide range of HVAC needs for growers; those items keep selling, and we aren't noticing much of a pullback. At this point, it's simply a matter of giving the consumables portion of our operations time to recover and return to where it was.

Joe Altobello

analyst
#31

Chris, I'd like to build on what you said a moment ago about California. If prices begin to rise, how fast could those <<inaudible>> cultivators scale things up?

Chris Hagedorn

executive
#32

Quite quickly, honestly. It really hinges on where they are in the construction process. We've received solid information indicating that quite a few substantially completed grows in California can be picked up right now through a possible acquisition. So we're aware that certain grows are just sitting there, partially or nearly finished, with the owners holding off on completion until conditions in the market bounce back. Once prices make a comeback and sort of push cultivators to re-engage, we'd anticipate a fairly swift rebound. So, to repeat, with those sites being mostly finished, I'd estimate it would definitely take fewer than 6 months, starting from when demand picks up, before those operators could run at maximum capacity. And honestly, I believe it could be even quicker than that.

Jim Hagedorn

executive
#33

I mean, isn't it also the case that in the legacy market—or whatever term you use, traditional markets—this is sort of a gypsy business, right, where folks are able to jump in and out really fast.

Chris Hagedorn

executive
#34

Yeah. Yeah, that has consistently been true. So regarding the — and obviously, if we can tell what the legal situation is for the individuals buying what we make, we're selling into retail, and after that point, where it ends up is basically impossible to predict. But we know there are plenty of black market cultivators around, which we refer to as legacy market growers; those people might stop operating for a quarter simply because they've got 4 lights in a garage, or 6 lights down in a basement. And for them it's sort of extra income. If the payoff they're getting doesn't justify the danger involved, they'll stop and wait for that market to bounce back. And all of that equipment is just sitting there ready to be turned on again; so that rebound is essentially immediate. And as I've mentioned, our expectation is that wholesale prices will begin to come back within the first 2 months of the new calendar year. And once that happens, we anticipate market recovery will follow.

Joe Altobello

analyst
#35

All right, that's useful. Then one last thing for Cory. How much do you expect commodity and logistics pressures to increase in '22, in dollar terms? And it seems — tell me if I've got this wrong — that those price hikes, the high single-digit ones, roughly speaking, don't just cancel that out dollar for dollar, but you also keep your margins intact in both businesses.

Cory Miller

executive
#36

Right. When we consider the rates we're building into the plan, for each segment. At the plan we've now put together, the segments are essentially holding margin steady. If I think about the headwind we've dealt with up to now, around $85 million, which we had in '21, that figure will be annualized, as we move into facing those higher rates on those commodities, across all of '22 or at minimum our whole purchasing cycle. So that's a headwind. Still, the pricing we're implementing ought to counteract it, and when it comes to commodities, we should be roughly margin neutral.

Eric Bosshard

analyst
#37

I'm trying to get a handle on how much pricing matters for the Hawthorne business, and I mean pricing of the finished product. Chris, I found your point interesting — that your exposure sits at the premium end. So I'm trying to reconcile that with the fact that your business has gotten softer right now, and it doesn't look like the softness is at the premium end. What I'm trying to figure out is: when cannabis prices decline, does that hurt you? Does it even matter to you? Is that shifting? Could you just walk me through it?

Jim Hagedorn

executive
#38

Sure. Our emphasis is on the premium segment, but we actually have fairly wide exposure; a number of our highest-volume items get used across what you could call the whole quality range. I mean items such as our growing media products, things like grow down. Anyone cultivating at any quality tier, whatever their position in the market, buys those items; and wholesale prices definitely, wholesale finished-product prices definitely were relevant for us; that was one thing we examined when we did a postmortem of what took place back in 2018, trying to gain a bit more predictability since we understood it would recur in some shape or form, and here we are. One of the — one of the main leading indicators we honed in on was that wholesale cannabis price, in the illicit market as well as the legacy market. And we believe we have decent feelers in both of those spaces to pin down what we consider fairly accurate prices. The premium players are fairly shielded from that downward pressure, though not shielded entirely. So when price per pound of outdoor flower reached all-time lows, and I mean far under $500 a pound at wholesale for outdoor flower, the premium indoor operators have experienced some price depression too. It simply hasn't been anywhere near the same degree; so if somebody in the indoor market could have gotten $4,000 for a pound of flower a year ago, they might be at $3,200 or $3,000 today; so they've still faced considerable downward pressure on price; it's just — again, it's been quite well shielded compared with the outdoor operators. Now again, so we do see some effect from those folks. But again, we sell a lot of product at the outdoor into the light dep greenhouse segment too. It's simply not where the core of our product line is focused.

Eric Bosshard

analyst
#39

And so, regarding what you're assuming about the direction of the business — does it function the way you'd like it to, given current pricing? Or does pricing need to return, or partially return, to its previous level?

Chris Hagedorn

executive
#40

Well, I mean, clearly, if wholesale prices come back up, that helps us. Growers end up with additional money on hand, and they'll have more to spend at our retail partners; so we're eager for a rebound. With that said, I mean, at the end of the day, this is a very long-term and highly speculative conversation. I believe the majority of folks watching this sector anticipate that eventually, there will be downward pressure on cannabis prices that persists over a longer horizon. And in part, that falls on the cannabis industry at large, and something we're more enthusiastic about potentially shaping, once we truly launch the Apollo, the Hawthorne Collective strategy, is stopping this product from becoming commoditized. Our board, investors, and others have asked us a million times, what will keep this from turning into tomatoes or lettuce — first off, I think you folks have been saying not — actually, not you specifically, but folks have been discussing how this <<inaudible>> could move outdoors, and margins, and prices would be destroyed, and that simply hasn't occurred. And — nor do we anticipate it occurring. We've long argued that it will remain mostly indoor and greenhouse. It's simply — there's far more control, and we can produce a superior product for the consumer, for the patient. We anticipate that pattern continuing, and we've talked with plenty of individuals who are, in my view, as knowledgeable and sharp about this area as anyone. People operating in both the illicit and licit markets for decades who think outdoor doesn't have a durable role here; we currently have products addressing sustainability challenges related to indoor cultivation. And once more, you're able to be far more exact in how you manage that environment. To return to what you asked, well, we'd like to see prices bounce back. We have a — business that's constructed, and can endure, even if prices don't fully recover, but we don't think that will happen.

Eric Bosshard

analyst
#41

All right. Then a question that follows up for Jim — you made a remark I realize you never promised, about opportunities that change the game, where this company might grow to twice its size within the next 5 years. Does that mean Apollo as a whole? Is that the route you're describing to reach those?

Jim Hagedorn

executive
#42

No. Yes, yes and no; it's the 5 pillars that do it. I think you're — as I said, we hold the view that the consumer business has more growth in it, our legacy consumer business. Clearly, on direct-to-consumer we hold the view that growth comes faster. Live goods, we think, is actually a big piece of that. Hawthorne, in the hydro supply space, we keep seeing returns for us there that are above average. And then the Apollo side gets added on top of that, and I think reaching those numbers is pretty easy. I mean, a lot of stuff has to happen correctly. But I think the answer is it's all of them.

Jim King

executive
#43

Hey management, let me jump in briefly — for the sake of time, we'll do just 1 additional question, and after that we'll close things out.

Jeff Zekauskas

analyst
#44

Appreciate you finding room for me. Reading certain press coverage out of California, you see assertions that the state's market amounts to roughly 2 million pounds while capacity sits at 6 million pounds. In other words, supply runs 2x to 3x beyond demand. Would you call that an accurate description? Then, second, input costs keep climbing. Specifically, should we anticipate those costs being greater in the December quarter, and then greater still in Q1 of the coming year? And if raw materials indeed keep getting more expensive into next year, how do you handle that dialogue with your buyers?

Chris Hagedorn

executive
#45

I'll handle the first portion of that. This is Chris. Yeah, I don't think — claiming California's capacity is 3x what gets sold within the state domestically, that strikes me as not crazy whatsoever. Since California has for a long time been — you mentioned America's breadbasket, well, for 30 years they've occupied that role for cannabis in America. So the entire illicit market, or legacy market, which still exists, a massive share of it gets supplied by legacy cultivators in California. So there are somewhat odd dynamics involved in entering a market where — the legal market faces a constraint around interstate commerce, while the legacy market clearly faces no such constraints. Consequently you get dynamics that can look strange, unless you peer really just 1 layer below the surface, which is that California provides a massive lion's share of black market cannabis nationwide; therefore you must account for that; now look, it's something we anticipate shifting across the next few years as East Coast markets develop their own legal domestic supply. We anticipate the market balancing somewhat more evenly between the East and West Coasts, though that hasn't occurred as of yet.

Jeff Zekauskas

analyst
#46

All right. And when it comes to our commodities, I'd say the majority are sitting at multiyear highs — oil, natural gas, multiyear highs. On plastic, we're observing a bit of a slowdown. So that's beginning to pause. Urea is roughly at a 9-year high. So if it's climbing, we don't believe it can climb much further before it levels off or at minimum eases somewhat; and so in our plan, we're expecting cost to sort of level off and ease somewhat. Of course, there's risk around that. And should costs keep climbing, we'll need to consider other measures to try to counter that. But if you consider what customers would be telling you, I believe they're witnessing it in every category, unlike what we've witnessed. In the past, when a cost rises on a particular commodity, customers are witnessing cost increases across all items in their store, and the consumer will have to bear that. The entire market will have to work that out. But we're not at a disadvantage versus the market.

Jim Hagedorn

executive
#47

I just want to mention that in the cost of goods portion regarding Hawthorne, if that was worth focusing on in terms of pricing. I think we're facing — this is truly business-to-business, sales to professionals who, I think, grasp, sort of what's going on in the global supply chain, and that many of our products, particularly sort of the hard side, are pricier, but there's plenty of advantage to owning them, and it represents the capacity to earn more money for them; and these folks, to the degree that I do know them, it's a very thrilling place to encounter these generally young folks, with good businesses, that are earning good money. And I don't think they view our products as sort of the back breaker. I do think on the consumer side, and we've discussed this a few times, I don't think, we know how the American consumer will react to the cost pressures on pretty much everything that they purchase. Personally, I think it's not healthy. I've stated that previously, and that I don't know. I hope there's a lesson than what happened in Virginia, and in other states, is that I think bringing inflation under control, and getting America's supply chain fixed is really crucial, because ultimately, it's going to result in, I think, problems with consumers' capacity to buy stuff. Now if we want to speak positively about that, this made our first rodeo, okay? And when the economy gets too tough, people still want to buy, have a nice house, and protect the value of their house, and they garden, when they can't do other things, we are highly resistant to recession, and therefore, I don't feel frightened about it. When it comes to the consumer side, honestly, no one can predict what will occur with consumer demand, given a situation where you're seeing essentially double-digit inflation; and calling that an exaggeration wouldn't be right, in my view. A couple of weeks back, I was down in D.C., and each senator I talked with — quite a few senators — asked, do you think it's transitory. My answer was no, and I believe it's actually speeding up. So I don't believe we have clarity — regarding Hawthorne, those folks are professionals, and it doesn't account for that massive a portion of their cost of goods; when it comes to the consumer side, that's a more troubling matter for America. And I think our position relative to it is a good one; but once more, I don't think anyone has the answer. In my view, everybody ought to be worried.

Jim King

executive
#48

Appreciate that, Madison. And thank you all for being here this morning. I'm aware a few people were waiting in line and we simply couldn't reach them due to how tight our schedule ran. So please don't hesitate to ring me up whenever you like during the next few days, today included. The number is (937) 578 to 5622. Also, so everyone can mark their calendars, right now we're tentatively planning February 2 for releasing our Q1 earnings results and holding the conference call. We'll speak with you at that point.

Jim Hagedorn

executive
#49

Wait a moment, everyone, before you all start. There's something I want to put on the table that I proposed to King. I'm certain this will come back to bite me. For those folks, especially, who have an interest in what's happening with Hawthorne, the work we're doing is genuinely strong. And I've pushed Jim to figure out a path for the investment community to truly see what we've got going on, since I believe it would make an impression on you; and I believe it matters for how you grasp our business that we create some methods to display a sort of what we're doing, so it isn't merely a couple of minutes during the call, it's a genuine chance to say, I think they are truly transforming the game. So I'd urge you to request it, and Jim to make it happen.

Executive

executive
#50

Okay, everyone. That said, I’m ready for your questions. We’ll speak with you once more on February 2. Thank you, all. Enjoy the rest of your day.

Operator

operator
#51

This concludes today's call. Thank you all for your participation. You may now disconnect.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete The Scotts Miracle-Gro Company transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to The Scotts Miracle-Gro Company earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in The Scotts Miracle-Gro Company or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.